Sfoglia per AUTORE
PASSAMONTI F
Collezione AOU Città della Salute di Torino

  

Items : 32

2025
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Tomassetti S; Lunghi F; Cavazzini F; Pocali B; Binotto G; Tiribelli M; Brociner M; Vallisa D; Falcone AP; Caocci G; De Stefano V; Gardellini A; Elli EM; Bonifacio M; Farina G; Micucci G; Benevolo G; Morsia E; Pastore D; Polizzi V; Tafuri A; Urbano T; Liberati AM; Itri F; Ditonno P; Carli G; Langella M; Ricco A; Impera S; et alii...

Decoding the historical tale: COVID-19 impact on haematological malignancy patients-EPICOVIDEHA insights from 2020 to 2022. in EClinicalMedicine / EClinicalMedicine. 2024 Mar 18;71:102553. doi: 10.1016/j.eclinm.2024.102553. eCollection 2024 May.
2024
AOU Alessandria
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Pagano L; Cornely OA; Koehler P; Rahimli L; Hanáková M; Rá?il Z; Bonanni M; Nygaard M; García-Bordallo D; Çolak GM; Mayer J; Sacchi MV; Krekeler C; Infante MS; Jindra P; Zompi S; Mitrovi? M; Miškovi? B; Mladenovi? M; Coppola N; Otaševi? V; Prattes J; Gavriilaki E; Tragiannidis A; Groh A; Serrano L; Drgo?a ?; Serris A; Gonzaga Y; et alii...

Need for ICU and outcome of critically ill patients with COVID-19 and haematological malignancies: results from the EPICOVIDEHA survey. in Infection / Infection. 2024 Jun;52(3):1125-1141. doi: 10.1007/s15010-023-02169-7. Epub 2024 Feb 22.
2024
AOU Alessandria
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Rasch S; Rahimli L; Cornely OA; Pagano L; Dibos M; Bavastro M; Prattes J; Egger M; Limongelli A; Cvetanoski M; García-Sanz R; Arellano E; Zambrotta GPM; Aiello TF; Wolf D; Núñez-Martín-Buitrago L; Nunes Rodrigues R; Hersby DS; Hanakova M; Víšek B; Cabirta A; Nordlander A; ?er?an M; Gräfe SK; Mladenovi? M; Miškovi? B; Ilhan O; Ammatuna E; Çolak GM; et alii...

2024
AOU Alessandria
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Dibos M; Cvetanoski M; Bavastro M; Limongelli A; Egger M; Prattes J; García-Sanz R; Aiello TF; Arellano E; Wolf D; Núñez-Martín-Buitrago L; Zambrotta GPM; Hersby DS; Nunes Rodrigues R; Nordlander A; Víšek B; Cabirta A; Gräfe SK; Ammatuna E; Hanakova M; ?er?an M; Çolak GM; Ilhan O; Bara? A; Mladenovi? M; Miškovi? B; Kohn M; Emarah Z; Stojanoski Z; et alii...

2023
AOU Città della Salute di Torino
AOU Novara

Foà R; Curti A; Passamonti F; Sartor C; Buzzatti E; Barozzi E; De Roberto P; Canzi M; Santoro L; Tagliaferri E; Zappasodi P; Cerrano M; Del Principe MI; Defina M; Todisco E; Gurrieri C; Dargenio M; Bonifacio M; Scappini B; Imovilli A; Lunghi M; Lazzarotto D; Forghieri F; Salutari P; Annunziata M; Giglio F; Chiaretti S; Vitale A; Papayannidis C; et alii...

Real-World Validation of Molecular International Prognostic Scoring System for Myelodysplastic Syndromes. in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2023 May 20;41(15):2827-2842. doi: 10.1200/JCO.22.01784. Epub 2023 Mar 17.
2023
AOU Città della Salute di Torino

Diez-Campelo M; Santini V; Kordasti S; Germing U; Santoro A; Savevski V; Passamonti F; Rambaldi A; Bolli N; Bicchieri M; Nibourel O; Riva E; Zampini M; Oliva EN; Riva M; Voso MT; Giaccone L; Lanino L; Chiusolo P; Mannina D; Russo A; Campagna A; Ubezio M; Tentori CA; D'Amico S; Borin L; Rivoli G; Vago L; Di Grazia C; et alii...

SARS-CoV-2 infection and vaccination in patients with hairy-cell leukaemia. in British journal of haematology / Br J Haematol. 2023 May;201(3):411-416. doi: 10.1111/bjh.18606. Epub 2022 Dec 20.
2023
AOU Alessandria
AOU Città della Salute di Torino

Corradini P; Passamonti F; Bertù L; Pulsoni A; Rivela P; Massaia M; Busca A; Falini B; Della Porta MG; Vallisa D; Cattaneo C; Capponi M; Bruna R; Tisi MC; Selleri C; Gozzetti A; Broccoli A; De Carolis L; Morotti A; Romano A; D'Elia GM; Candoni A; Marchetti M; Mancini A; Tiacci E;

SARS-CoV-2 Infection in Patients With Waldenström's Macroglobulinemia: A Multicenter International Cohort Study. in HemaSphere / Hemasphere. 2023 Jun 2;7(6):e887. doi: 10.1097/HS9.0000000000000887. eCollection 2023 Jun.
2023
AOU Città della Salute di Torino

Defrancesco I; Ferretti VV; Morel P; Kyriakou C; Kastritis E; Tohidi-Esfahani I; Tedeschi A; Buske C; García-Sanz R; Vos JMI; Peri V; Margiotta Casaluci G; Ferrari A; Piazza F; Oostvogels R; Lovato E; Montes L; Fornecker LM; Grunenberg A; Dimopoulos MA; Tam CS; D'Sa S; Leblond V; Trotman J; Passamonti F; Arcaini L; Varettoni M;

COVID-19 in adult acute myeloid leukemia patients: a long-term follow-up study from the European Hematology Association survey (EPICOVIDEHA). in Haematologica / Haematologica. 2023 Jan 1;108(1):22-33. doi: 10.3324/haematol.2022.280847.
2023
AOU Alessandria
AOU Città della Salute di Torino

Hoenigl M; Ammatuna E; Busca A; Corradini P; Rahimli L; Gräfe S; Khostelidi S; Martín-González JA; García-Poutón N; Sacchi MV; Rodrigues RN; Booth S; Sciumè M; Zambrotta G; Hanakova M; El-Ashwah S; Cordoba R; Calbacho M; Bahr NC; Cattaneo C; De Ramón-Sánchez C; Fazzi R; Glenthøj A; Sramek J; Kulasekararaj A; Jindra P; Navrátil M; Piedimonte M; Petzer V; et alii...

SARS-CoV-2 infection in patients with chronic lymphocytic leukemia: The Italian Hematology Alliance on COVID-19 cohort. in Hematological oncology / Hematol Oncol. 2023 Feb;41(1):128-138. doi: 10.1002/hon.3092. Epub 2022 Oct 25.
2023
AOU Alessandria
AO Cuneo
AOU Città della Salute di Torino
AOU Novara

Visco C; Corradini P; Passamonti F; Bertù L; Gherlinzoni F; Pagano L; Guidetti A; Cilloni D; Visani G; Federici AB; Tisi MC; Cudillo L; Galimberti S; Coviello E; Della Porta MG; Mohamed S; Mauro FR; Gentile M; Gambacorti-Passerini C; Massaia M; Bocchia M; Billio A; Cattaneo C; Derenzini E; Scattolin A; Marchesi F; Fracchiolla NS; Arcaini L; Trentin L; et alii...

Age, successive waves, immunization, and mortality in elderly COVID-19 hematological patients: EPICOVIDEHA findings. in International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases / Int J Infect Dis. 2023 Dec;137:98-110. doi: 10.1016/j.ijid.2023.10.013. Epub 2023 Oct 18.
2023
AOU Alessandria
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Pagano L; Cordoba R; Cornely OA; Hanakova M; Rahimli L; Sacchi MV; Nunes Rodrigues R; Hersby DS; Ammatuna E; Cabirta A; Zambrotta GPM; Nordlander A; Arellano E; Mladenovi? M; Aiello TF; Núñez-Martín-Buitrago L; Gräfe SK; Miškovi? B; Emarah Z; García-Sanz R; Çolak GM; Wolf D; Limongelli A; Ilhan O; Calbacho M; Bara? A; Bavastro M; Merelli M; Biernat MM; et alii...

Incidence of blast phase in myelofibrosis according to anemia severity. in EJHaem / EJHaem. 2023 Jul 17;4(3):679-689. doi: 10.1002/jha2.745. eCollection 2023 Aug.
2023
AOU Città della Salute di Torino

Barbui T; Borsani O; Devos T; Ross DM; Benevolo G; Silver RT; Albano F; Gotlib J; Polverelli N; Elli EM; Kiladjian JJ; De Stefano V; Iurlo A; Palandri F; Kuykendall A; Caramella M; Guglielmelli P; Rumi E; Mora B; Maffioli M; Porta MGD; Bertù L; Komrokji R; Vannucchi AM; Passamonti F;

Prediction of thrombosis in post-polycythemia vera and post-essential thrombocythemia myelofibrosis: a study on 1258 patients. in Leukemia / Leukemia. 2022 Oct;36(10):2453-2460. doi: 10.1038/s41375-022-01673-3. Epub 2022 Aug 30.
2022
AOU Città della Salute di Torino

Mora B; Guglielmelli P; Kuykendall A; Rumi E; Maffioli M; Palandri F; De Stefano V; Caramella M; Salmoiraghi S; Kiladjian JJ; Gotlib J; Iurlo A; Cervantes F; Ruggeri M; Silver RT; Albano F; Benevolo G; Ross DM; Della Porta MG; Devos T; Rotunno G; Komrokji RS; Casetti IC; Merli M; Brociner M; Caramazza D; Auteri G; Barbui T; Cattaneo D; et alii...

COVID-19 in vaccinated adult patients with hematological malignancies: preliminary results from EPICOVIDEHA. in Blood / Blood. 2022 Mar 10;139(10):1588-1592. doi: 10.1182/blood.2021014124.
2022
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Corradini P; Busca A; Rá?il Z; Hernández-Rivas JÁ; Jaksic O; Jiménez-Lorenzo MJ; Nunes-Rodrigues R; González-López TJ; Karlsson LK; Córdoba-Mascuñano R; Glenthøj A; Loureiro-Amigo J; Malak S; Ribera-Santa Susana JM; Serrano L; Weinbergerová B; Bilgin YM; Calbacho M; Labrador J; Sili U; van Doesum J; Dragonetti G; Falces-Romero I; Gomes-Silva M; Itri F; Lamure S; López-García A; Marchesi F; Salmanton-García J; et alii...

COVID-19 and hairy-cell leukemia: an EPICOVIDEHA survey. in Blood advances / Blood Adv. 2022 Jul 12;6(13):3870-3874. doi: 10.1182/bloodadvances.2022007357.
2022
AOU Alessandria
AOU Città della Salute di Torino

Passamonti F; Pagliuca A; Koehler P; Klimko N; Corradini P; Hoenigl M; Busca A; Zompi S; Sacchi MV; Nunes Rodrigues R; Nordlander A; Essame J; Cordoba R; Batini? J; Bergantim R; Bilgin YM; Blennow O; Cattaneo C; Duarte RF; Emarah Z; Gomes da Silva M; González-López TJ; Kulasekararaj A; Ledoux MP; López-García A; Merelli M; Prezioso L; Ilhan O; Seval GC; et alii...

A prognostic model for patients with lymphoma and COVID-19: a multicentre cohort study. in Blood advances / Blood Adv. 2022 Jan 11;6(1):327-338. doi: 10.1182/bloodadvances.2021005691.
2022
AOU Alessandria
AO Cuneo
AOU Città della Salute di Torino
AOU Novara

Corradini P; Merli F; Passamonti F; Candoni A; Krampera M; Venditti A; Selleri C; Tosi P; Lanza F; Conconi A; La Barbera EO; Gambacorti-Passerini C; Visani G; Vallisa D; Rigacci L; Armiento D; Gherlinzoni F; Tafuri A; Galimberti S; Bocchia M; Corso A; Cilloni D; Cardinali V; Turrini M; Trentin L; Cuneo A; Della Porta M; Massaia M; Fracchiolla N; et alii...

Breakthrough COVID-19 in vaccinated patients with hematologic malignancies: results from the EPICOVIDEHA survey. in Blood / Blood. 2022 Dec 29;140(26):2773-2787. doi: 10.1182/blood.2022017257.
2022
AOU Alessandria
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Corradini P; Pagliuca A; Passamonti F; Bonanni M; Labrador J; Rahimli L; Verga L; Cattaneo C; Adži?-Vuki?evi? T; Machado M; Gräfe S; Sili U; Hanáková M; Nucci M; Mladenovi? M; Liévin R; Prezioso L; Rá?il Z; Guidetti A; Demirkan F; Sacchi MV; Fernández N; Zambrotta G; Fouquet G; Marchetti M; Batini? J; Aujayeb A; de Jonge N; de Ramón C; et alii...

Direct-Acting Antivirals as Primary Treatment for Hepatitis C Virus-Associated Indolent Non-Hodgkin Lymphomas: The BArT Study of the Fondazione Italiana Linfomi. in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2022 Dec 10;40(35):4060-4070. doi: 10.1200/JCO.22.00668. Epub 2022 Jun 17.
2022
AOU Città della Salute di Torino

Passamonti F; Marcheselli L; Zignego AL; Visco C; Russo F; Chimienti E; Zuccaro V; Sacchi P; Santoro A; Pulsoni A; Vallisa D; Dodero A; Perbellini O; Ferreri AJM; Orsucci L; Piazza F; Re F; Motta M; Rattotti S; Spina M; Merli M; Luminari S; Paulli M; Bruno R; Arcaini L;

Secondary infections worsen the outcome of COVID-19 in patients with hematological malignancies: A report from the ITA-HEMA-COV. in Hematological oncology / Hematol Oncol. 2022 Dec;40(5):846-856. doi: 10.1002/hon.3048. Epub 2022 Aug 12.
2022
AO Cuneo
AOU Città della Salute di Torino

Corradini P; Passamonti F; Antonio Grossi P; Bruno R; Pagano L; Luppi M; Busca A; Giuliani N; Corso A; Mohamed S; Tosi P; Giovanni Della Porta M; Lanza F; Rigacci L; Massimo Lemoli R; Venditti A; Tafuri A; Billio A; Gentile M; Falini B; Turrini M; Chiara Tisi M; Morotti A; Coviello E; Trentin L; Bocchia M; Galimberti S; Cuneo A; Musto P; et alii...

COVID-19 and CAR T cells: a report on current challenges and future directions from the EPICOVIDEHA survey by EHA-IDWP. in Blood advances / Blood Adv. 2022 Apr 12;6(7):2427-2433. doi: 10.1182/bloodadvances.2021005616.
2022
AOU Città della Salute di Torino

Busca A; Salmanton-García J; Corradini P; Marchesi F; Cabirta A; Di Blasi R; Dulery R; Lamure S; Farina F; Weinbergerová B; Batini? J; Nordlander A; López-García A; Drgo?a ?; Espigado-Tocino I; Falces-Romero I; García-Sanz R; García-Vidal C; Guidetti A; Khanna N; Kulasekararaj A; Maertens J; Hoenigl M; Klimko N; Koehler P; Pagliuca A; Passamonti F; Cornely OA; Pagano L; et alii...

COVID-19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA). in Journal of hematology & oncology / J Hematol Oncol. 2021 Oct 14;14(1):168. doi: 10.1186/s13045-021-01177-0.
2021
AOU Alessandria
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Nordlander A; Borbényi Z; Çolak GM; Hanakova M; El-Ashwah S; Shapetska M; Karlsson LK; Regalado-Artamendi I; Gonzaga Y; Nygaard M; Batini? J; Essame J; Mancini V; Shwaylia H; Sciumè M; Núñez-Martín-Buitrago L; Nunes-Rodrigues R; Ammatuna E; Obr A; Herbrecht R; Izuzquiza M; Oberti M; Salvini M; Ciceri F; Booth S; López-García A; Sacchi MV; Mayer J; Bonuomo V; et alii...

COVID-19 elicits an impaired antibody response against SARS-CoV-2 in patients with haematological malignancies. in British journal of haematology / Br J Haematol. 2021 Nov;195(3):371-377. doi: 10.1111/bjh.17704. Epub 2021 Jul 16.
2021
AOU Alessandria
AO Cuneo
AOU Città della Salute di Torino
AOU Novara

Corradini P; Pagano L; Grossi PA; Bertù L; Zaja F; Musto P; Petrucci L; Lanza F; Visani G; Mina R; La Barbera EO; Cattaneo C; Candoni A; Krampera M; Luppi M; Cardinali V; Galimberti S; Armiento D; Bocchia M; Marchesi F; Fracchiolla N; Tafuri A; Pinto A; Arcaini L; Massaia M; Ladetto M; Busca A; Venditti A; Farina F; et alii...

EPICOVIDEHA: A Ready to Use Platform for Epidemiological Studies in Hematological Patients With COVID-19. in HemaSphere / Hemasphere. 2021 Jun 25;5(7):e612. doi: 10.1097/HS9.0000000000000612. eCollection 2021 Jul.
2021
AOU Città della Salute di Torino

Salmanton-García J; Busca A; Cornely OA; Corradini P; Hoenigl M; Klimko N; Marchesi F; Pagliuca A; Passamonti F; Koehler P; Pagano L;

Classification and Personalized Prognostic Assessment on the Basis of Clinical and Genomic Features in Myelodysplastic Syndromes. in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2021 Apr 10;39(11):1223-1233. doi: 10.1200/JCO.20.01659. Epub 2021 Feb 4.
2021
AOU Città della Salute di Torino

Palomo L; Sole F; Kordasti S; Kern W; Rambaldi A; Bolli N; Ciceri F; Passamonti F; Remondini D; Giampieri E; Savevski V; Saitta C; Campagna A; Morabito L; Ubezio M; Riva M; Oliva E; Voso MT; Bacigalupo A; Santini V; Bonifazi F; Bruno B; Borin L; Bernardi M; Angelucci E; Termanini A; Maggioni G; Rossi M; Zampini M; et alii...

Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study. in The Lancet. Haematology / Lancet Haematol. 2020 Oct;7(10):e737-e745. doi: 10.1016/S2352-3026(20)30251-9. Epub 2020 Aug 13.
2020
AOU Alessandria
AO Cuneo
AOU Città della Salute di Torino
AOU Novara

Corradini P; Pagano L; Bertù L; Corrao G; Grossi PA; Franchi M; Oberti M; Zappasodi P; Visco C; Armiento D; Pane F; Pinto A; Galieni P; Rigacci L; Candoni A; Venditti A; Fava C; Federici AB; Marchesi F; Musto P; Gentile M; Bocchia M; Di Renzo N; Olivieri A; Ferrandina C; Selleri C; Ortu La Barbera E; Luppi M; Scattolin AM; et alii...

Impact of bone marrow fibrosis grade in post-polycythemia vera and post-essential thrombocythemia myelofibrosis: A study of the MYSEC group. in American journal of hematology / Am J Hematol. 2020 Jan;95(1):E1-E3. doi: 10.1002/ajh.25644. Epub 2019 Nov 1.
2020
AOU Città della Salute di Torino

Agnoli S; Siracusa C; Accetta R; Uccella S; Cavalloni C; Benevolo G; Albano F; Silver RT; Ruggeri M; De Stefano V; Palandri F; Devos T; Iurlo A; Cervantes F; Gotlib J; Kiladjian JJ; Komrokji RS; Caramella M; Rambaldi A; Barraco D; Maffioli M; Rumi E; Guglielmelli P; Mora B; Merli M; Barbui T; Bertù L; Cazzola M; Vannucchi AM; et alii...

Eltrombopag for immune thrombocytopenia secondary to chronic lymphoproliferative disorders: a phase 2 multicenter study. in Blood / Blood. 2019 Nov 14;134(20):1708-1711. doi: 10.1182/blood.2019001617.
2019
AOU Alessandria
AOU Città della Salute di Torino

Borchiellini A; Motta G; Rambaldi A; Passamonti F; Lucchini E; Carli G; Santi RM; Volpetti S; Quaresimini G; Merli M; Valeri F; Romano A; Rodeghiero F; Visco C; d'Amore ESG; Ruggeri M;

A phase Ib study to assess the efficacy and safety of vismodegib in combination with ruxolitinib in patients with intermediate- or high-risk myelofibrosis. in Journal of hematology & oncology / J Hematol Oncol. 2018 Sep 24;11(1):122. doi: 10.1186/s13045-018-0661-x.
2018
AOU Città della Salute di Torino

Couban S; Benevolo G; Donnellan W; Cultrera J; Koschmieder S; Verstovsek S; Hooper G; Hertig C; Tandon M; Dimier N; Malhi V; Passamonti F; Couban S; Benevolo G; Donnellan W; Cultrera J; Koschmieder S; Verstovsek S; Hooper G; Hertig C; Tandon M; Dimier N; Malhi V; Passamonti F;

2018
AOU Città della Salute di Torino

Barraco D; Mora B; Guglielmelli P; Rumi E; Maffioli M; Rambaldi A; Caramella M; Komrokji R; Gotlib J; Kiladjian JJ; Cervantes F; Devos T; Palandri F; De Stefano V; Ruggeri M; Silver RT; Benevolo G; Albano F; Merli M; Pietra D; Barbui T; Rotunno G; Cazzola M; Giorgino T; Vannucchi AM; Passamonti F; Barraco D; Mora B; Guglielmelli P; et alii...

Ruxolitinib for the treatment of inadequately controlled polycythemia vera without splenomegaly: 80-week follow-up from the RESPONSE-2 trial. in Annals of hematology / Ann Hematol. 2018 Sep;97(9):1591-1600. doi: 10.1007/s00277-018-3365-y. Epub 2018 May 27.
2018
AOU Città della Salute di Torino

Bensasson C; Guglielmelli P; Sivgin S; Devos T; Callum J; Egyed M; Palandri F; Benevolo G; Saydam G; Griesshammer M; Khan M; Ronco JP; Passamonti F; Griesshammer M; Saydam G; Palandri F; Benevolo G; Egyed M; Callum J; Devos T; Sivgin S; Guglielmelli P; Bensasson C; Khan M; Ronco JP; Passamonti F;

Ruxolitinib for the treatment of inadequately controlled polycythaemia vera without splenomegaly (RESPONSE-2): a randomised, open-label, phase 3b study. in The Lancet. Oncology / Lancet Oncol. 2017 Jan;18(1):88-99. doi: 10.1016/S1470-2045(16)30558-7. Epub 2016 Dec 2.
2017
AOU Città della Salute di Torino

Bensasson C; Sivgin S; Vannucchi AM; Callum J; Devos T; Egyed M; Benevolo G; Palandri F; Griesshammer M; Passamonti F; Khan M; Mounedji N; Saydam G;

2017
AOU Città della Salute di Torino

Passamonti F; Giorgino T; Mora B; Guglielmelli P; Rumi E; Maffioli M; Rambaldi A; Caramella M; Komrokji R; Gotlib J; Kiladjian JJ; Cervantes F; Devos T; Palandri F; De Stefano V; Ruggeri M; Silver RT; Benevolo G; Albano F; Caramazza D; Merli M; Pietra D; Casalone R; Rotunno G; Barbui T; Cazzola M; Vannucchi AM; Passamonti F; Giorgino T; et alii...